Ayrton Capital LLC 13D/13G Filings for PharmaCyte Biotech, Inc. (PMCB)

Ayrton Capital LLC 13D and 13G filings for PharmaCyte Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-13
1:42 pm
Sale		 2024-12-31 13G PharmaCyte Biotech, Inc.
PMCB		 Ayrton Capital LLC 774,100
9.900%		 -182,129decrease
(-19.05%)		 Filing
2024-02-14
3:38 pm
Sale		 2023-12-31 13G PharmaCyte Biotech, Inc.
PMCB		 Ayrton Capital LLC 956,229
9.900%		 -794,483decrease
(-45.38%)		 Filing
2023-05-19
5:19 pm
Purchase		 2022-12-31 13G PharmaCyte Biotech, Inc.
PMCB		 Ayrton Capital LLC 1,750,712
9.990%		 1,750,712increase
(New Position)		 Filing